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Abstract
Several components of the mosquito immune system including the RNA interference (RNAi), JAK/STAT, Toll and IMD
pathways have previously been implicated in controlling arbovirus infections. In contrast, the role of the phenoloxidase (PO)
cascade in mosquito antiviral immunity is unknown. Here we show that conditioned medium from the Aedes albopictus-
derived U4.4 cell line contains a functional PO cascade, which is activated by the bacterium Escherichia coli and the
arbovirus Semliki Forest virus (SFV) (Togaviridae; Alphavirus). Production of recombinant SFV expressing the PO cascade
inhibitor Egf1.0 blocked PO activity in U4.4 cell- conditioned medium, which resulted in enhanced spread of SFV. Infection
of adult female Aedes aegypti by feeding mosquitoes a bloodmeal containing Egf1.0-expressing SFV increased virus
replication and mosquito mortality. Collectively, these results suggest the PO cascade of mosquitoes plays an important role
in immune defence against arboviruses.
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Introduction
The transmission of arboviruses by mosquitoes and other
arthropod vectors has considerable adverse impacts on human and
animal health. This group of pathogens consists primarily of
viruses in the families Flaviviridae, Togaviridae Bunyaviridae, and
Reoviridae [1–4]. Arboviruses replicate in both vertebrate and
arthropod hosts. In mosquitoes, arboviruses must also spread from
the midgut, which is the initial site of infection following a
bloodmeal to the salivary glands for transmission to another
vertebrate host. The genus Alphavirus (family Togaviridae) contains
several mosquito-vectored arboviruses including models like
Sindbis virus (SINV) and Semliki Forest virus (SFV) [5,6] but
also the re-emerging human pathogen chikungunya virus
(CHIKV) [7]. The genetic structure and replication of alpha-
viruses, which replicate in the cytoplasm, have been analysed in
detail [5,6,8,9]. All members of the genus have positive-stranded
RNA genomes that are approximately 11–12 kb in size, and have
59 caps and 39 poly(A) tails (genetic structure of SFV shown in
Fig. 1A). All alphaviruses also encode two major polyproteins. The
59 encoded non-structural polyprotein P1234 is proteolytically
cleaved into replicase proteins nsP1–4 while the 39 encoded
structural polyprotein (translated from a subgenomic mRNA,
which is transcribed under control of a subgenomic promoter) is
proteolytically cleaved into the structural proteins that form the
capsid and envelope of the virion. The glycosylated envelope
proteins play key roles in entry into cells by mediating virus
binding to host cell receptor(s) and subsequent fusion to
endosomes (though other entry mechanisms may be possible)
while the capsid protein encapsulates the viral genome [10–12].
Infection of mosquito cell cultures has also been useful to study
arbovirus replication, thus allowing increasingly detailed studies of
arbovirus/vector interactions [13,14].
The innate immune system of mosquitoes plays an important
role in the control of arbovirus infections, and SFV has proven to
be a good models to study mosquito antiviral response mecha-
nisms [14]. A key antiviral defence is RNAi (reviewed in [14–17]),
which also influences arbovirus spread and transmission [18,19].
In addition, differential regulation of mosquito immune signalling
pathways and other host genes has been described following
infection by dengue virus (DENV), West Nile virus (WNV) and
SINV [20–24]. JAK/STAT and Toll signalling pathways both
mediate antiviral activity against DENV [23,24]. Interestingly,
infection of Anopheles gambiae with the alphavirus o’nyong-nyong
(ONNV) did not result in upregulation of the Toll and JAK/
STAT pathways although other genes involved in immunity were
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upregulated with some displaying antiviral activities [25]. Innate
immune signalling can also inhibit SFV replication in mosquito
cells [26], while experiments in Drosophila melanogaster suggest that
replication of SINV is inhibited by the IMD pathway [27].
Another conserved component of the insect immune system is
the extracellular phenoloxidase (PO) cascade, which generates
cytotoxic intermediates and the formation of melanin following
wounding or infection [28–32]. Several factors have been shown
to activate the PO cascade including pathogen-associated molec-
ular pattern molecules like bacterial peptidoglycan. Other
components of the cascade include multiple clip-domain serine
proteases (cSPs) whose activation results in processing of the
zymogen prophenoloxidase (PPO or proPO) to form active PO.
PO then catalyses the conversion of mono- and di-phenolic
substrates to quinones, which are converted to melanin.
A number of studies have shown that deposition of melanin
provides defence against bacteria and multicellular parasites, while
intermediates like 5,6-dihydroxyindole have been shown to be
cytotoxic and act against pathogens [29,33,34]. Studies with the
lepidopteran Heliothis virescens (tobacco budworm) indicate that
haemolymph also contains factors with antiviral activity against
Helicoperva zea single capsid nucleopolyhedrovirus (HzSNPV) and
other viruses including SINV, while bioassays with 5,6-dihydrox-
yindole show that it rapidly inactives Autographa californica multi-
capsid nucleopolyhedrosis virus (AcMNPV) [35–38]. Haemo-
lymph melanisation in Lepidoptera also correlates with antiviral
activity against Microplitis demolitor bracovirus (MdBV) [39], and
Lymantria dispar multicapsid nucleopolyhedrovirus [40]. Whether
arboviruses activate the PO cascade in mosquitoes and whether
products of the PO cascade exhibit biologically relevant antiviral
activity remains unclear, although interestingly RNAi knockdown
of PPO I in the mosquito Armigeres subalbatus by a recombinant
SINV expressing a dsRNA targeting PPO I resulted in reduced
PO activity and higher SINV titres [41].
Figure 1. Viruses used in study. (A) SFV (prototype strain SFV4). (B) SFV(3H)-FFLuc-Egf1.0F and SFV(3H)-FFLuc-Egf1.0R, encoding Firefly luciferase
(FFLuc) as part of the non-structural polyprotein (inserted between duplicated nsP2 cleavage sites at the nsP3/4 junction), and from a duplicated
subgenomic promoter the melanisation inhibitor Egf1.0 in sense (F virus; top) or (as negative control) antisense orientation (R virus; bottom). (C)
SFV(3F)-ZsGreen-Egf1.0F and SFV(3F)-ZsGreen-Egf1.0R, expressing ZsGreen inserted into the C-terminal region of nsP3, and from a duplicated
subgenomic promoter the melanisation inhibitor Egf1.0 in sense (F virus; top) or (as negative control) antisense orientation (R virus; bottom).
doi:10.1371/journal.ppat.1002977.g001
Author Summary
Arboviruses are transmitted to vertebrates by arthropod
vectors such as mosquitoes. Infection of mosquitoes with
arboviruses activates immune defence responses including
the RNA interference pathway. Another component of the
insect immune system is the phenoloxidase (PO) cascade,
which produces melanin that accumulates at wound sites
and around invading microorganisms. Some pathogen-
associated pattern recognition molecules are known to
activate the PO cascade, which results in the proteolytic
processing of inactive prophenoloxidase (PPO) to PO. PO
then catalyses the formation of compounds that ultimately
form melanin. Some of these products are also known to
have anti-microbial properties but whether activation of
the PO cascade provides any defence against arboviruses
is unclear. Using the arbovirus, Semliki Forest virus, we
show that this virus activates the PO cascade. By using
recombinant Semliki Forest virus expressing an inhibitor of
the PO cascade, we also demonstrate that this pathway
inhibits virus spread in cell culture. Moreover, inhibition of
this pathway leads to higher virus genome levels and
higher mortality of infected mosquitoes. In conclusion,
Semliki Forest virus activates the PO cascade which
exhibits antiviral activity and can be added to the list of
mosquito anti-viral defence mechanisms.
PO-Mediated Antiviral Activity Against SFV
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Previous studies show that Aedes albopictus-derived U4.4 cells
have a functional antiviral RNAi response and immune signalling
pathways [26,42]. Here we show that conditioned medium from
U4.4 cells contains inducible PO activity that is activated by
exposure to bacteria and purified SFV particles. Expression of the
PO cascade inhibitor Egf1.0 from MdBV [39,43] by SFV
decreased PO activity in U4.4 cell conditioned medium and
enhanced the spread of virus through cell cultures. Infection of Ae.
aegypti mosquitoes with SFV expressing Egf1.0 resulted in
enhanced viral replication and mosquito mortality. Taken
together, our results establish a role for the PO cascade in
mosquito immune defence against an arbovirus.
Results
Immune challenge by bacteria and SFV increases PO
activity in U4.4 cell-conditioned medium
The haemolymph of mosquitoes melanises in response to a
variety of stimuli including wounding and infection [28].
Mosquitoes including Ae. aegypti encode multiple PPO genes, with
some family members being inducibly expressed in response to
microbial infection [44–47]. Haemocyte-like cell lines from An.
gambiae also express multiple PPO genes [48], and recent studies
identify cSP CLIPB9 as a candidate PAP [49].
Since the U4.4 cell line from Ae. albopictus is an important
model for studying immune responses against arboviruses
[26,42,50], we first asked whether conditioned medium from
this cell line exhibited an increase in melanisation upon
exposure to SFV or the bacterium Escherichia coli which is a
well known elicitor of the PO cascade. Using a standard
spectrophotometric assay for measuring melanisation activity
(see Materials and Methods), our results indicated that PO
activity significantly increased in U4.4 cell conditioned medium
following exposure to each microbe (p = 0.003; E. coli versus
control, p = 0.004; SFV versus control, p = 0.021; E. coli versus
SFV, p = 1.00) (Fig. 2A). Our results also indicated that a 1 h
incubation in conditioned medium significantly reduced SFV
viability relative to virus incubated in unconditioned medium
(p = 0.011) (Fig. 2B).
Because amphipathic molecules like detergents and alcohol
activate insect PPOs [51], intracellular PO activity is commonly
assayed for in PO producing cells like haemocytes by first fixing
them in methanol and then incubating in a substrate like
dopamine, which PO utilizes to produce melanin. This in turn
causes the fixed cell to turn black or darken. In the case of Ae.
aegypti and An. gambiae, prior studies establish that one class of
haemocytes, oenocytoids, constitutively exhibit intracellular PO
activity while a second class, granulocytes, inducibly exhibit
intracellular PO activity following immune challenge with
bacteria [52,53]. To assess whether U4.4 cells exhibit intracel-
lular PO activity, we fixed cells in glacial methanol and then
incubated them in buffer plus dopamine. Our results showed no
intracellular PO activity in the majority of cells but a small
fraction of cells (0.2%) darkened in manner similar to mosquito
haemocytes (Fig. 2C) [52,53]. We also noted that these
melanising cells display a rounded morphology and appear
larger than other U4.4 cells that do not darken after fixation and
incubation with substrate. We thus concluded from these assays
that U4.4 cell-conditioned medium melanises following exposure
to SFV or bacteria, and that a small proportion of U4.4 cells also
melanise after fixation. We also concluded the increase in
melanisation activity that occurs in conditioned medium corre-
lates with a reduction in SFV viability.
Expression of Egf1.0 by SFV inhibits PO activity in U4.4
cell-conditioned medium
As previously noted, the PO cascade consists of multiple
proteases that terminate with the zymogen PPO [28–32] (Fig. 3A).
The number of proteolytic steps in the cascade has not been fully
characterised in any insect including mosquitoes. However, it is
known that infection, wounding, and other challenges trigger
activation of upstream serine proteases, which result in processing
of proPAPs (also referred to as pro-PPAEs or pro-PPAFs) between
their clip and protease domains. Activated PAPs then process PPO
by cleavage at a conserved arginine-phenylalanine (R-F) site in the
N-terminal domain of the protein, which results in formation of
PO (Fig. 3B). PO catalyses the hydroxylation of monophenols like
tyrosine to o-diphenols and the oxidation of o-diphenols to
quinones. Quinones thereafter undergo further enzymatic and
non-enzymatic reactions that produce cytotoxic intermediates and
ultimately melanin. Negative regulation of the PO cascade occurs
through endogenous protease inhibitors like serpins, while
reducing agents in haemolymph like glutathione (GSH) likely
inhibit melanisation by reducing PO-generated quinones back to
diphenols [54] (Fig. 3A). Several pathogenic organisms have also
evolved strategies to suppress the PO cascade of hosts [28]. One of
these is the virus MdBV, which produces the protein Egf1.0.
Functional characterization of Egf1.0 showed that it blocks
haemolymph melanisation in diverse insects including mosquitoes
through two activities (Fig. 3A, B). First, it competitively inhibits
activated PAPs because it contains an R-F reactive site that mimics
the cleavage site for PPO [39]. Second, Egf1.0 contains another
domain that prevents upstream proteases from processing pro-
PAPs [43].
Given this background, we asked whether Egf1.0 could inhibit
the increase in melanisation activity that occurs in U4.4 cell-
conditioned medium following exposure to SFV or E. coli. To
answer this question, we produced two sets of constructs. In the
first, we cloned the egf1.0 gene from MdBV [39] in forward
(expressing the Egf1.0 protein) and reverse (negative control not
expressing Egf1.0) orientation into SFV under control of a second
subgenomic promoter to produce SFV4(3H)-FFLuc-Egf1.0F and
SFV4(3H)-FFLuc-Egf1.0R (Fig. 1B). These viruses also expressed
Firefly luciferase (FFLuc), which served as an indicator for viral
replication and spread through a U4.4 cell culture as previously
shown for reporter gene-expressing SFV [50] (Fig. 1B). The
second set of SFV constructs expressed Egf1.0 in forward or
reverse orientation from a second subgenomic promoter plus
ZsGreen fluorescent protein inserted into the C-terminal region of
nsP3 to produce SFV4(3F)-ZsGreen-Egf1.0F and SFV4(3F)-ZsGreen-
Egf1.0R, respectively (Fig. 1C).
Next, the properties of SFV-expressed Egf1.0 were analysed.
We infected U4.4 cells with SFV4(3F)-ZsGreen-Egf1.0F and
SFV4(3F)-ZsGreen-Egf1.0R at a multiplicity of infection (MOI) of
10. Immunoblot analysis of cell lysates confirmed that each
recombinant virus actively replicated as evidenced by detection of
the nsP3-ZsGreen protein (Fig. 4A). Using an anti-Egf1.0
antibody, we also detected full-length Egf1.0 [39,43] in the
medium and lysates prepared from U4.4 cells infected with
SFV4(3F)-ZsGreen-Egf1.0F but did not detect this protein in
medium or lysates from uninfected cells or cells infected with
SFV4(3F)-ZsGreen-Egf1.0R (Fig. 4A). Our Egf1.0 antibody also
detected several other bands smaller than full-length Egf1.0 in
samples infected with SFV4(3F)-ZsGreen-Egf1.0F including a
17.6 kDa protein that corresponded to the size of the C-terminal
Egf1.0 fragment that prior studies showed is produced after
cleavage by a PAP (Fig. 4A). Expression of Egf1.0 by SFV4(3H)-
PO-Mediated Antiviral Activity Against SFV
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FFLuc-Egf1.0F and absence of Egf1.0 expression by SFV4(3H)-
FFLuc-Egf1.0R were also verified by immunoblotting (not shown).
We then analyzed the functional properties of SFV-expressed
Egf1.0 in conditioned medium from U4.4 cells. Melanisation
assays at 48 h post-infection (p.i.) showed that conditioned
medium from cells infected with SFV4(3H)-FFLuc-Egf1.0F exhib-
ited very low PO activity, which was very similar and not
significantly different to conditioned medium from uninfected
(control) U4.4 cells (p = 1.0) (Fig. 4B). In contrast, medium from
cells infected with SFV4(3H)-FFLuc-Egf1.0R exhibited PO activity
levels that were significantly higher than medium from uninfected
control cells (p = 0.025) (Fig. 4B). Conditioned medium of U4.4
cells infected with SFV4(3H)-FFLuc-Egf1.0F also contained
significantly less (75%) PO activity than medium from cells
infected with control virus SFV4(3H)-FFLuc-Egf1.0R (p,0.001)
(Fig. 4B). The addition of E. coli to medium from SFV- infected
cells had no effect on the PO activity (p = 0.251). As shown in
Fig. 4B, the addition of E. coli to medium from SFV4(3H)-FFLuc-
Egf1.0F-infected cells did not increase PO activity as would be
expected if Egf1.0 was inhibiting PAP activity. Addition of E. coli
to medium from SFV4(3H)-FFLuc-Egf1.0R-infected cells also did
not elevate PO activity beyond the elevated level of activity that
Figure 2. PO activity in U4.4 cell-conditioned medium. (A) PO activity in conditioned medium without immune challenge (Control) or after the
addition of E. coli or purified SFV virions. One unit (U) of PO activity was defined as DA490 = 0.001 after 30 minutes incubation (see Materials and
Methods). Each bar represents the mean from 10 reactions; error bars show standard deviation. This experiment was repeated three times with similar
results. (B) SFV virion viability after a 1 h incubation at 28uC in unconditioned culture medium or medium conditioned by U4.4 cells for 48 h. Viability
was then determined by titration of SFV on BHK-21 cells. PFU: plaque forming units. Each bar represents the mean from triplicate incubations; error
bars show standard deviation. This experiment was repeated three times with similar results. (C) Staining for intracellular PO activity in U4.4 cells.
Arrow indicates a U4.4 cell that melanised after fixation and incubation with the PO substrate dopamine. Note the larger size of this cell and its
rounded morphology relative to surrounding cells that have not melanised.
doi:10.1371/journal.ppat.1002977.g002
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Figure 3. Activation and inhibition of the melanisation pathway. (A) Schematic showing the insect PO cascade and the known mode of
action of Egf1.0. Infection by different pathogens and external wounding both trigger activation of the PO cascade. Proteins in the haemolymph
known as humoral pattern recognition receptors (PRRs) bind to factors on the surface of different pathogens. This interaction as well as external
wounding trigger the activation of multiple serine proteases. Some of these proteases have been identified in different insect species, whereas others
remain unknown. Activation of these proteases leads to activation of prophenoloxidase activating proteases (proPAPs to PAPs). Some PAPs also
require serine protease homologs (SPHs) for function, which are themselves activated by upstream serine proteases. PAPs cleave proPO (also called
PPO) to PO, which oxidizes mono- and diphenolic substrates to quinones that undergo further reactions to form melanin. A number of these
intermediate products are cytotoxic including some that have also been shown to inactivate viruses (see Text). Serine protease inhibitors called
serpins have been identified from different species of insects that inhibit PAPs or other proteases in the pathway. In the absence of wounding or
infection, the reducing agent glutathione (GSH) also exists in haemolymph at concentrations that can inhibit melanisation by recycling quinones to
diphenols. The inhibitor Egf1.0 from MdBV inhibits both the processing of proPAPs and PAPs that have already been activated. (B) Alignment of the
reactive site loop of Egf1.0 to the predicted cleavage sites for the PPOs encoded by Ae. aegypti (indicated as AedAePPO). Note the identical P1–P19
residues R-F (underlined) of Egf1.0 and PPO family members. Black highlighting indicates identical residues. UniProt database identifiers in
parentheses to the left of the alignment.
doi:10.1371/journal.ppat.1002977.g003
PO-Mediated Antiviral Activity Against SFV
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Figure 4. Recombinant SFV expresses Egf1.0 and inhibits PO activity in U4.4 cell-conditioned medium. (A) Immunoblots showing
Egf1.0 expression and secretion from mosquito cells. U4.4 cells were infected with SFV4(3F)-ZsGreen-Egf1.0F or SFV4(3F)-ZsGreen-Egf1.0R at an MOI of
10 followed by preparation of cell lysate and medium samples at 48 h p.i. as indicated in the Materials and Methods. The left blot was probed with an
anti-SFV nsP3 antibody with individual lanes labeled as follows: U4.4 cells infected with SFV4(3F)-ZsGreen-Egf1.0R (R = cell lysate, Rm= conditioned
medium), U4.4 cells infected with SFV4(3F)-ZsGreen-Egf1.0F (F = cell lysate, Fm= conditioned medium), or uninfected cells (U = cell lysate,
Um= conditioned medium). Black star identifies the nsP3-ZsGreen protein, only detected in lysates from SFV-infected cells. Black diamond indicates
bovine serum albumin (non-specifically detected because of high abundance). The right blot shows the same samples probed with an anti-Egf1.0
antibody. A control lane (C) was added to this blot (purified, recombinant Egf1.0). Note that Egf1.0 is only detected in the control lane, and F and Fm
lanes. Black arrow indicates uncut Egf1.0; open arrow identifies a band corresponding to the predicted C-terminal domain of Egf1.0 after PAP
cleavage. Molecular mass markers indicated to the left. (B) PO activity in conditioned medium from uninfected U4.4 cells (Control), cells infected with
SFV4(3H)-FFLuc-Egf1.0F (Egf1.0F), SFV4(3H)-FFLuc-Egf1.0R (Egf1.0R), cells infected with SFV4(3H)-FFLuc-Egf1.0F with E. coli added to the medium
(Egf1.0F+E. coli), cells infected with SFV4(3H)-FFLuc-Egf1.0R with E. coli added to the medium (Egf1.0R+E. coli), or medium from uninfected cells with E.
coli added (E. coli). PO activity was measured as outlined in Fig. 2A; 1 ml of conditioned medium was taken at 48 h p.i. from 2.66105 U4.4 cells
infected at an MOI of 10, or uninfected (Control). Each bar represents the mean from 10 reactions; error bars show standard deviation. This
experiment was repeated three times with similar results.
doi:10.1371/journal.ppat.1002977.g004
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already existed. Taken together, these results showed that
SFV4(3H)-FFLuc-Egf1.0F produced Egf1.0 in U4.4 cells, which
is secreted into the medium. Given prior evidence that Egf1.0
specifically inhibits the PO cascade by disabling PAP function,
these data also strongly suggested that U4.4 cell-conditioned
medium contains a functional PO cascade, which is activated by
SFV or gram-negative bacteria, and which is inhibited by SFV-
produced Egf1.0.
The inhibitor Egf1.0 enhances SFV spread through U4.4
cell culture
We next asked whether inhibition of PO activity by Egf1.0
could enhance virus spread during an infection. We first used our
SFV4(3H)-FFLuc-Egf1.0F or SFV4(3H)-FFLuc-Egf1.0R constructs
which allowed us to monitor viral replication and spread through a
U4.4 cell culture by measuring FFluc activity at 24 h and 48 h p.i.,
similar to previously described experiments [50]. Infections were
carried out at either a high multiplicity of infection (MOI 10),
where most U4.4 cells were infected and little or no further spread
of virus could occur, or a low MOI (0.005) where only a small
fraction of cells were initially infected and SFV could thereafter
disseminate through the medium to infect other cells. Overall
GLM revealed differences in FFLuc activity as a function of MOI
(10 or 0.005), construct (SFV4(3H)-FFLuc-Egf1.0F or SFV4(3H)-
FFLuc-Egf1.0R) and sample time (24 h or 48 h p.i.) (Fig. 5 A&B,
p= 0.012). As a result the data from the high and low MOI
treatments were examined separately.
At an MOI of 10, cells infected with SFV4(3H)-FFLuc-Egf1.0F
or SFV4(3H)-FFLuc-Egf1.0R exhibited similar levels of FFluc
activity at 24 h or 48 h p.i. (p = 0.74) (Fig. 5A). This outcome was
fully consistent with most cells being infected and containing
actively replicating SFV, while also indicating that Egf1.0 had no
effect on intracellular replication activity. As expected, rates of
replication also dropped to low levels for both recombinant viruses
at 48 h p.i. (p,0.001) as they each entered the persistent phase of
infection [26] (Fig. 5A). In contrast, we observed a very different
outcome when cells were infected at a low MOI where FFluc
activity differed between cells infected with SFV4(3H)-FFLuc-
Egf1.0F or SFV4(3H)-FFLuc-Egf1.0R. At 24 h p.i, there was no
difference in FFLuc activity between cells infected with SFV4(3H)-
FFLuc-Egf1.0F and SFV4(3H)-FFLuc-Egf1.0R (p = 0.37), but at
48 h p.i. SFV4(3H)-FFLuc-Egf1.0F showed significantly higher
spread and replication rates than SFV4(3H)-FFLuc-Egf1.0R
(p = 0.004) (Fig. 5A). We reasoned that this difference was also
most likely linked to the time required for Egf1.0 to be expressed
and secreted, and infectious SFV to be produced.
Repeating these experiments using SFV4(3F)-ZsGreen-Egf1.0F
and SFV4(3F)-ZsGreen-Egf1.0R allowed us to visualize virus spread
from one cell to another through the green fluorescing foci that
form from ZsGreen presence in viral replication complexes
(ZsGreen is inserted into the C-terminal region of nsP3; Fig. 1C).
At a high MOI of 10, most U4.4 cells contained green foci at 48 h
when infected with SFV4(3F)-ZsGreen-Egf1.0F or SFV4(3F)-
ZsGreen-Egf1.0R (Fig. 5B). At a low MOI of 0.005, however,
more cells exhibited green foci at 48 h p.i. when infected with
SFV4(3F)-ZsGreen-Egf1.0F than SFV4(3F)-ZsGreen-Egf1.0R
(Fig. 5B).
Overall, these data strongly suggested that activation of the PO
cascade by SFV reduced virus spread, whereas Egf1.0 enhances
virus spread by inhibiting the PO cascade. However, these results
did not provide any insight into the identity of the effector
molecules produced by the PO cascade that reduce SFV viability
and spread. To assess whether the anti-SFV effects of PO were due
to the formation of reactive intermediates or other products
formed by PO, we infected U4.4 cells with a low MOI of
SFV4(3H)-FFLuc-Egf1.0R (MOI 0.005) and added GSH
(0.5 mM), which as noted above likely inhibits melanisation by
reducing quinones (see Fig. 3A) [54]. Our results showed that
GSH significantly increased the spread of SFV4-FFLuc-Egf1.0R
relative to medium without added GSH (p,0.001). As expected
though, the addition of GSH did not change the rate of spread of
SFV4(3H)-FFLuc-Egf1.0F (p = 0.139) (Fig. 6A).
Although vertebrates lack a PO cascade, we also tested whether
expression of Egf1.0 conferred a replicative advantage to SFV in
BHK-21 cells. There was no significant difference in the spread of
SFV4(3H)-FFLuc-Egf1.0F and SFV4(3H)-FFLuc-Egf1.0R (p= 0.64)
following low MOI infection (0.005), indicating that Egf1.0 had no
effect on dissemination of SFV in this mammalian cell line (Fig. 6B).
PO activity protects mosquitoes following SFV infection
Immunologically important antiviral pathways in mosquitoes
such as RNAi have been previously implicated in promoting
mosquito survival after arbovirus infection. Indeed, inhibition of
the RNAi pathway through alphavirus-expressed RNAi inhibitors
results in rapid death of virus-infected mosquitoes [55,56]. To test
whether the PO cascade provides an effective antiviral defence in
mosquitoes, we extended our experiments to Ae. aegypti, a mosquito
species that is generally relevant as an arbovirus vector, and which
has also been shown to transmit SFV in the laboratory [57–59].
Prior studies also implicate Ae. aegypti alongside Ae. africanus as a
natural vector of SFV [60]. Ae. aegypti were fed bloodmeals
containing SFV4(3H)-FFLuc-Egf1.0F, SFV4(3H)-FFLuc-Egf1.0R,
or no virus (mock-infection). We then monitored mosquito survival
(cohorts of 22–25 mosquitoes) following infection in three
independent experiments to determine survival rates (Fig. 7A).
Since no significant differences were detected within treatments in
the three experiments (p.0.05), the samples were pooled for
further analysis. Overall, mosquito survival differed significantly
among treatments (Kaplan Meier x2 = 25.37; p,0.001). Post Hoc
multiple comparison tests revealed no significant difference in
survival rates between the mock-infected control and mosquitoes
infected with SFV4(3H)-FFLuc-Egf1.0R (p= 0.98). In contrast,
mosquitoes infected with SFV4(3H)-FFLuc-Egf1.0F exhibited
higher mortality than mock-infected mosquitoes (p,0.001) or
mosquitoes infected with SFV4(3H)-FFLuc-Egf1.0R (p,0.001). In
conclusion, inhibition of the PO cascade decreased survival
following infection of mosquitoes with SFV.
To assess whether the reduced survival of SFV4(3H)-FFLuc-
Egf1.0F-infected mosquitoes was associated with enhanced viral
replication, mosquitoes (cohorts of 10) were fed bloodmeals
containing SFV4(3H)-FFLuc-Egf1.0F or SFV4(3H)-FFLuc-
Egf1.0R. Total RNA was then extracted at 3 days post-
bloodmeal followed by qPCR analysis to determine SFV genome
copy number per individual. This time point was chosen because
it just precedes quantifiable differences in mosquito survival, thus
avoiding mortality-induced bias. Our results showed that viral
genome copy numbers were higher in mosquitoes fed SFV4(3H)-
FFLuc-Egf1.0F than in mosquitoes fed SFV4(3H)-FFLuc-Egf1.0R
(Mann-Whitney test, p = 0.04) (Fig. 7B). Interestingly, infection
rates were also higher when mosquitoes were infected
with SFV4(3H)-FFLuc-Egf1.0F than SFV4(3H)-FFLuc-Egf1.0R
(Fig. 7B). This suggests that Egf1.0-mediated inhibition of the
PO cascade is also potentially important in establishment of an
infection. Higher infection rates have been previously observed
with alphaviruses expressing RNAi inhibitors or following
silencing of antiviral RNAi genes during mosquito infection
[55,61].
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Figure 5. Inhibition of PO activity enhances the spread of SFV in U4.4 cells. (A) U4.4 cells were infected with SFV4(3H)-FFLuc-Egf1.0F
(Egf1.0F) or SFV4(3H)-FFLuc-Egf1.0R (Egf1.0R) at an MOI of 10 (left graph) or 0.005 (right graph). FFLuc activity (expressed in lights units) was
determined at 24 or 48 h p.i. Each bar represents the mean from triplicate cultures; error bars show standard deviation. This experiment was repeated
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Discussion
Comparative genome analysis of different mosquito species
reveals a noticeable expansion of PPO genes relative to other
insects. For example, An. gambiae encodes nine PPOs while Ae.
aegypti encodes ten. Expansion in the numbers of clip-domain
serine proteases and serpins has also occurred [47]. The recent
sequencing of the Culex quinquefasciatus genome reveals nine PPOs
and thirty-two serpins, compared to originally twenty-three serpins
in Ae. aegypti though recent studies and Vectorbase increase this
number to twenty-six [45–47,62]. Compared to other insects
including An. gambiae, relatively little is known about regulation of
the PO cascade in mosquitoes although recent studies in Ae. aegypti
identify some of the processes involved [62]. Interestingly the cSP
family also contains proteins with non-catalytic protease domain,
so-called clip domain serine protease homologs (cSPHs), and both
cSPs and cSPHs (as co-factors) are involved in melanisation
reactions.
In Ae. aegypti and An. gambiae, cSPs and cSPHs are divided into
five subfamilies called CLIP A, B, C, D and E [47]. Mainly CLIP
B subfamily proteases are known (or suggested) to activate PPOs.
Melanisation in Ae. aegypti was found to be regulated by protease
inhibitor Serpins-1, -2 and -3 which regulate different cSPs [62].
In that study, two separate pathways leading to PPO cleavage
were described; a first pathway linking Serpin-1 to (CLIP B
subfamily members) Immune melanisation protease (IMP)-1 and
IMP-2, and a second pathway linking Serpin-2 to Tissue
melanisation protease (TMP) and IMP-1. Depletion of Serpin-2
leads to tissue melanisation and appears to be involved in
activation of the Toll pathway, while depletion of Serpin-1 leads
to immune responses against the parasite Plasmodium gallinaceum
[62]. Other regulators of melanisation in Ae. aegypti such as CLSP2
(a modular protein consisting of C-type lectin and elastase-like
domains) have been described [63]. Transcription of at least some
PPO genes in Ae. aegypti is also regulated by the Toll pathway [44],
thus linking different branches of the immune response.
Based on the antiviral activities of insect haemolymph [35,36],
we hypothesized that immune reactions induced by PO extend to
arboviral infection of mosquitoes. Our experiments collectively
indicate that U4.4 cell-conditioned medium contains a functional
PO cascade. Our detection of a small proportion of U4.4 cells that
melanise after fixation and incubation with dopamine further
suggest these cells are likely source of the PO activity detected in
conditioned medium. Notably, these cells morphologically resem-
ble oenocytoids, which also comprise less than 1% of the
circulating haemocyte population in mosquitoes like Ae. aegypti
and An. gambiae [52,53] as well as many other insects, yet are also
the primary source of PO in plasma [51]. Ongoing analysis of the
U4.4 cell transcriptome indicates that PPO orthologs are
expressed although at this time it remains unclear whether
expression is restricted to the large, rounded cells that stain after
incubation with dopamine or is more global. Regardless of these
uncertainties, our results strongly indicate that medium condi-
tioned by U4.4 cells contains a functional PO cascade that is
activated by exposure to SFV or E. coli, and is inhibited by Egf1.0.
Prior studies in Lepidoptera show that MdBV also activates the
PO cascade [39] while bacterial cell wall components like
peptidoglycan are well known activators of the PO cascade in a
three times with similar results. (B) Epifluorescent micrographs of U4.4 cells 48 h p.i. with SFV4(3F)-ZsGreen-Egf1.0F at an MOI of 10 (P1), SFV4(3F)-
ZsGreen-Egf1.0F at an MOI of 0.005 (P3), SFV4(3F)-ZsGreen-Egf1.0R at an MOI of 10 (P2), or SFV4(3F)-ZsGreen-Egf1.0R at an MOI of 0.005 (P4). Arrows
point to ZsGreen-positive replication foci in the cytoplasm of selected U4.4 cells. Cell nuclei are counterstained with marker TOPRO3. Note at low MOI
infection the increased number of replication foci in cells infected with SFV4(3F)-ZsGreen-Egf1.0F (P3) relative to cells infected with SFV4(3F)-ZsGreen-
Egf1.0R (P4). This experiment was repeated three times with similar results.
doi:10.1371/journal.ppat.1002977.g005
Figure 6. Spread of SFV in mosquito and vertebrate cells. (A) The addition of glutathione (GSH) to medium enhances the spread of SFV. U4.4
cells were infected with SFV4(3H)-FFLuc-Egf1.0F (Egf1.0F) or SFV4(3H)-FFLuc-Egf1.0R (Egf1.0R) at an MOI of 0.005 followed by determination of FFLuc
activity at 48 h p.i. + GSH: 0.5 mM GSH; 2 GSH: negative control. Each bar represents the mean from triplicate cultures; error bars show standard
deviation. This experiment was repeated three times with similar results. (B) Egf1.0 has no effect on SFV spread in BHK-21 cells. Cells were infected
with SFV4(3H)-FFLuc-Egf1.0F (Egf1.0F) or SFV4(3H)-FFLuc-Egf1.0R (Egf1.0R) at an MOI of 0.005 followed by determination of FFLuc activity at 24 h and
48 h p.i. Each bar represents the mean from triplicate cultures; error bars show standard deviation. This experiment was repeated three times with
similar results.
doi:10.1371/journal.ppat.1002977.g006
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Figure 7. Expression of Egf1.0 increases mortality of Ae. aegypti and replication of SFV in vivo. (A) Ae. aegypti were fed blood containing
SFV4(3H)-FFLuc-Egf1.0F or SFV4(3H)-FFLuc-Egf1.0R. Uninfected blood meals served as a control. Mosquito mortality was then monitored daily post-
bloodmeal. Combined survival data from three independent experiments (cohorts of 22–25 infected mosquitoes per virus or control mosquitoes in
each experiment) are shown. Error bars show standard deviation. (B) SFV genome copy number as determined by real time qPCR. Total RNA was
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diversity of insects [28–32]. We think it likely that activation of the
PO cascade in U4.4 cell-conditioned medium by E. coli similarly
involves binding of bacterial cell wall components by currently
unknown humoral pattern recognition receptors. In contrast, it
remains unclear what features of SFV induce a similar increase in
PO activity. One possibility is that glycoproteins of the viral
envelope function as pathogen-associated molecular patterns. The
lectin pathway of vertebrate complement is known to be activated
by pattern recognition receptors such as mannose–binding lectin
that binds mannose-containing glycoproteins [64]. Several lectins
have also been described as candidate pattern recognition
receptors in insects [65].
While additional studies will be needed to identify how SFV is
being recognised in U4.4 cell conditioned medium, our results
collectively indicate that activation of the PO cascade and the
associated increase in melanisation that occurs reduces the spread
of SFV among the U4.4 cell population. Reduced survival of Ae.
aegypti combined with enhanced virus replication when mosquitoes
are infected by SFV expressing Egf1.0 also suggests the PO
cascade is important in limiting arbovirus spread in mosquitoes.
Interestingly, gene expression data obtained following ONNV
infection of An. gambiae indirectly suggest that ONNV infection
may have led to activation of melanisation pathways in the early
stages of infection [25], which highlights the importance of this
study.
On the other hand, the effects of PO cascade inhibition on
mosquito survival are most apparent at later stages post-bloodmeal
compared to experiments with alphaviruses expressing RNAi
inhibitors [55,56]. This suggests that inhibition of the PO cascade
takes more time than disruption of RNAi or that this response is
less powerful than RNAi in defence against arboviruses. However
these experiments show that viral expression of an inhibitor is a
viable strategy for inhibiting insect immune responses. Expression
from the subgenomic promoter of recombinant SFV results in
high levels of Egf1.0 and strong inhibitory activity, which may be
difficult to achieve by just silencing a target gene through RNAi.
Thus, an important goal for future studies will be to assess how
inhibition of the PO cascade affects the spread of SFV in different
tissues of mosquitoes as well as how the PO cascade may interact
with other immune defence responses including the RNAi
pathway.
Previous experiments where PPO I was silenced in Ar. subalbatus
by expression of PPO I dsRNA using recombinant SINV showed
increased titres of SINV [41]. Our results take this observation
further by showing that activation of the PO cascade reduces SFV
viability in vitro and that Egf1.0-mediated inhibition enhances virus
replication and spread both in vitro and in vivo. However it is not
entirely clear what products generated by the PO cascade are
responsible for the antiviral activity against SFV we observe.
Given the antiviral properties of 5,6-dihydroxyindole against
AcMNPV [38], and the ability of GSH to inhibit anti-SFV activity
in conditioned U4.4 cell culture medium suggests that the reactive
intermediates generated by PO are antiviral. However, it is also
possible the PO cascade might reduce arbovirus spread from the
initial site of infection through the production of melanin and/or
activation of other signaling pathways like Toll or IMD that also
have roles in antiviral defence. To distinguish between these
possibilities will require studies that directly assess the effects of
5,6-dihydroxyindole, melanin, or other compounds on the
integrity of SFV virions [38]. Any damage to structural proteins
could result in failure to bind receptors and/or enter cells.
Questions also remain over the tissue specificity of PO activity.
Our in vitro and in vivo data overall suggest products of the PO
cascade may be antiviral because they reduce the viability of
virions in the haemocoel. However other research describes
melanisation reactions in the extracellular space between An.
gambiae midgut cells following Plasmodium berghei infection [66].
Thus inhibition of PO activity by Egf1.0 could enhance SFV
replication and spread in or around midgut tissues. Finally, our
study does not directly address the question of whether wild-type
SFV can potentially inhibit or evade the PO response. Given
though that SFV spread is enhanced by expression of a powerful
inhibitor like Egf1.0, we suspect the ability of wild-type SFV to
inhibit or evade host-associated PO defence response is likely
weak.
Alphaviruses are not inhibited by the Toll pathway in insects
[26,27], but links between the PO cascade and Toll signalling in
Ae. aegypti could, as noted above, play a role in antiviral defence.
Infection of Ae. aegypti with DENV-2 results in differential
regulation of serpins although it is not possible yet to speculate
whether these have a role in controlling PPO activation [24]. It
does however suggest that protease-mediated antiviral defences
extend to other arbovirus families. Intriguingly, it has been shown
that infection of insects with strains of endosymbyotic Wolbachia
bacteria, which can inhibit arbovirus infection by yet unknown
mechanisms [67], may upregulate melanisation or genes involved
in melanisation [68,69]. Thus, our findings also may explain in
part the antiviral properties mediated by Wolbachia infection.
Future work will determine whether these findings also extend to
viruses from other arbovirus families.
Materials and Methods
Ethics statement
Under UK Home Office legislation insects such as mosquitoes
are not considered animals. No animals were used in the course of
these experiments. Defibrinated sheep blood was obtained from
TCS Biosciences (Buckingham, United Kingdom).
Cells, viruses and infection
Ae. albopictus-derived U4.4 mosquito cells were grown at 28uC in
L-15 medium with 10% fetal calf serum and 10% tryptose
phosphate broth. BHK-21 cells were grown in Glasgow minimum
essential medium (GMEM) with 10% newborn calf serum and
10% tryptose phosphate broth at 37uC in a 5% CO2 atmosphere.
Amplification of SFV (strain SFV4) and recombinant clones
derived from SFV4 in BHK-21 cells (grown as described above),
together with titration of plaque forming units (PFU) in BHK-21
cells have been previously described [50]. SFV and derived clones
were purified from supernatant as described and resuspended in
TNE (Tris-NaCl-EDTA) buffer [70]. Viruses were diluted in
PBSA (PBS with 0.75% bovine serum albumin) and added to U4.4
cells at room temperature for 1 h followed by washing twice to
remove any unbound particles; cells were grown at 28uC following
infection. Details of reporter viruses (Fig. 1) can be obtained from
the authors. The pCMV-SFV4 backbone for production of SFV4
has been previously described [71]. A second subgenomic
promoter was placed behind the SFV4 structural open reading
extracted 3 days post-bloodmeal from mosquitoes infected with SFV4(3H)-FFLuc-Egf1.0F or SFV4(3H)-FFLuc-Egf1.0R. Viral genome RNA levels from 10
mosquitoes for each virus are shown. Values at 0 represent uninfected mosquitoes. Horizontal bar indicates average genome copy number from
infected mosquitoes. This experiment was repeated three times with similar results.
doi:10.1371/journal.ppat.1002977.g007
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frame for construction of viruses with duplicated subgenomic
promoters [72]. This second subgenomic promoter is of the T37/
17 type (consisting of a sequence 37 nucleotides upstream and 17
nucleotides downstream of the original transcription start-site of
the SFV subgenomic mRNA). The ZsGreen marker was inserted
into the C-terminal region of nsP3 via a XhoI site naturally
occuring in the genomic sequence (leading to expression of nsP3
containing ZsGreen), while Firefly luciferase (FFLuc) was inserted
between duplicated nsP2 cleavage sites at the nsP3/4 junction as a
cleavable reporter, using strategies previously shown [73]. The full
egf1.0 coding sequence (including signal peptide) derived from
MdBV was placed under control of the second subgenomic
promoter in sense or antisense (as negative control) orientation.
Detection of ZsGreen expression
Cells on glass slides were fixed in 10% formaldehyde (Fisher
Chemicals) for 45 min and washed in PBS three times. Cells were
treated with TO-PRO 3 (Invitrogen) (1:1000) in dH2O for 10 min
and washed with PBS three times. Slides were mounted using
Vectashield mounting medium (Vector Laboratories). Cells and
fluorescence were then visualised by confocal microscopy.
Detection of Egf1.0 by immunoblotting
At 48 h p.i., U4.4 cells infected with SFV (MOI of 10) or control
uninfected cells were lysed in Laemmli buffer. Conditioned cell
culture medium was concentrated on Millipore Centricon-Plus 70
Centrifugal Filter Units prior to addition of Laemmli buffer.
Recombinant Egf1.0 produced as previously described [39] served
as a positive control. Samples were run on a 4–20% Tris-Gycine
PAGEr precast gels (Lonza), and blotted onto Immobilon-P PVDF
membranes (Millipore). SFV infection was detected using a rabbit
anti-nsP3 antibody (1:20000), while Egf1.0 was detected using a
rabbit anti-Egf1.0 antibody (1:35000) [39,74]. Primary antibodies
were detected using a horseradish peroxidase (HRP)-conjugated goat-
anti rabbit secondary antibody (Jackson ImmunoResearch) (1:45000),
followed by visualisation using the ECL Advance Western Blotting
Kit (Amersham) and a GeneGnome bioimaging system (Syngene).
Mosquito rearing and infection
Aedes aegypti (Liverpool red eye strain optimised for filarial growth)
were kindly provided by R. M. Maizels and Y. Harcus (Institute of
Immunology and Infection Research, University of Edinburgh).
Mosquitoes were kept at 27uC, in 85% humidity and with a 16 h
light: 8 h dark photoperiod. Larvae were fed on a standard yeast
diet, while adults were fed on 10% fructose continuously. Female
adults were 4 to 5 days old when allowed to feed on defibrinated
sheep blood (TCS Biosciences) containing 56107 PFU of virus per
ml of blood supplemented with 4 mM ATP. Mosquitoes were
starved for 24 h before feeding and the bloodmeal (at 37uC)
provided by a Hemotek membrane feeder (Discovery Workshops,
Accrington, UK) for 2 h. Mosquitoes that fed were removed and
maintained at standard conditions with fructose.
Melanisation assays and determination of PO activity
Conditioned cell culture medium from Ae. albopictus-derived U4.4
mosquito cells was harvested 48 h post-cell seeding (46106 cells in a
75 cm2 flask) and centrifuged at 2000 rpm for 5 min in order to
eliminate residual cells. Approximately 5 ml of a pelleted E. coli
JM109 culture (New England Biolabs) or 3.56107 PFU of SFV
were added to 1 ml of cell culture medium and incubated for
10 min at room temperature. The mixture was then centrifuged at
3000 rpm for 10 min at 4uC in order to remove debris. Following
this, PO activity assays were carried out in 96-well plates with 100 ul
of 50 mM Sodium Phosphate buffer (pH 6.5) containing 2 mM
dopamine added to 20 ml of cell culture medium [75]. PO activity
was monitored by measuring absorbance at 490 nm using a plate
reader (Dynatech MR5000) over a period of 30 min. It should be
noted that this approach predominantly detects dopachrome and/
or dopaminechrome rather than melanin itself. One unit of PO
activity was defined as DA490= 0.001 after 30 minutes, similar to
previously described [39,76,77]. For each experimental condition,
PO activities from 10 reactions were determined. Intracellular PO
activity was assessed by first fixing U4.4 cells in glacial methanol.
After rinsing in PBS, fixed cells were then incubated for 1 h in
phosphate buffer plus 2 mM dopamine.
Determination of luciferase activities
Following cell lysis in Passive Lysis Buffer (Promega), luciferase
activities were determined by using a Dual Luciferase assay kit
(Promega) on a GloMax 20/20 luminometer.
Real time quantitative PCR analysis (qPCR)
SFV4 genome copy number was quantified as previously
described [26]. Briefly, total RNA was isolated from single Ae.
aegypti using Trizol (Invitrogen). RNA quality and quantity were
assessed with a NanoDrop 1000 spectrophotometer (Fisher
Scientific). A total of 0.5 mg of total RNA per mosquito was
reverse transcribed using Superscript III kit (Invitrogen) and oligo-
dT primer, and reactions were analysed in triplicate. The reaction
mix contained 0.8 mM of each primer, FastStart SYBR Green
Master x1 (Roche), and 2 ml of template. Tubes were heated to
94uC for 5 min, and then cycled through 94uC for 20 sec, 62uC
for 20 sec, and 72uC for 20 sec for 40 cycles on a RotorGene 3000
instrument (Corbett Research). Sequences of the primers were as
indicated: 59 -GCAAGAGGCAAACGAACAGA-39 (SFV-nsP3-
for) and 59 –GGGAAAAGATGAGCAAACCA-39 (SFV-nsP3-
rev). The number of SFV genome copies was calculated using a
standard curve generated with the plasmid pSFV1.
Statistical analysis
Data with 2 groups were analysed using either t-test or Mann
Whitney tests, depending on the structure of the data. Data with
more than 2 groups was analysed using General Linear Models
(GLM). All GLMs were initially performed including all fixed
effects and their interactions. Any post hoc tests were adjusted for
multiple comparisons using the Bonferroni correction. Survival
analysis was performed on cohorts of 22–25 mosquitoes.
Differences between survivorship curves were tested using
Kaplan-Meier estimator and the log-rank test. Where appropriate,
multiple comparisons were performed and the Bonferroni
correction was applied. All analyses were conducted using SAS
v9.1.3 (SAS Institute Inc., Cary, NC, USA). Diagnostics were
performed and plots of residuals were examined, confirming the
goodness-of-fit of all models. Prior to analysis, it was specified that
results with p,0.05 would be reported as exhibiting formal
statistical significance.
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